Kumar Ramesh

Traws Pharma, Inc.

Chief Executive Officer, Director

Avg. Two Year Performance

(87%) Avg. Purchase Return    (37%) Compound
96% Avg. Sale Return    40% Compound

Holdings: 102.23K shares

Last Three Months: 20-Jan-24 -- 19-Apr-24

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Hold

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions